Mural Oncology plc
MURA
$2.08
-$0.01-0.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -44.80% | 3.32% | -7.92% | -0.62% | -2.09% |
| Total Depreciation and Amortization | 33.96% | -1.96% | -3.45% | 0.00% | 6.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 955.64% | -60.10% | 138.58% | 137.15% | -153.62% |
| Change in Net Operating Assets | 324.73% | -934.01% | 71.80% | -86.16% | 126.25% |
| Cash from Operations | 14.77% | -15.83% | -5.63% | -2.45% | 21.37% |
| Capital Expenditure | 50.00% | 56.52% | -64.29% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -96.43% | -22.59% | 87.15% | -55.76% | 135.09% |
| Cash from Investing | -93.66% | -22.71% | 87.51% | -55.79% | 135.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -- | -100.00% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -236.99% | -297.57% | 142.05% | -173.79% | 108.85% |